Insights On Drug Development

  1. Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs 6/9/2026

    The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

  2. Accelerating Antibody Development: A Proven Path From Gene To GMP 6/5/2026

    Discover how an optimized, end-to-end development strategy can help sponsors reach key clinical milestones faster and bring potentially life-saving therapies to patients sooner.

  3. Faster Clones, Simpler Process: What's Changing In CHO Expression? 6/3/2026

    This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

  4. Accelerate Drug Development Through Strategic, Integrated Partnerships 6/3/2026

    Your next development partner could determine your program's success. Learn how leading biotech and pharma organizations use integrated partnerships to speed development and strengthen pipeline value.

  5. A Small Molecule cGMP Commercial Manufacturing Facility 6/2/2026

    A modern facility enables flexible, scalable small‑molecule drug production, showcasing advanced equipment, regulatory compliance, and smooth transition from development to commercial manufacturing.

  6. The Many Benefits Of Outsourcing Stability 6/2/2026

    Outsourcing stability testing improved efficiency, reduced costs, and enhanced scalability, enabling robust lifecycle support, regulatory compliance, and optimized resource utilization across programs.

  7. Faster Production Of Panbela's Pancreatic Cancer Drug 6/2/2026

    Process innovation reduced synthesis steps, increased yield, and improved chiral purity, enabling faster, scalable manufacturing of a pancreatic cancer therapy for clinical and commercial development.

  8. Developing A Multi-Drug Antiparasitic For Dogs 6/2/2026

    Complex formulation enabled a multi-drug antiparasitic therapy for dogs, achieving stability, palatability, and scalable clinical supply across multiple strengths within accelerated timelines.

  9. From Lab To Tox Batch: A First-Time-Right API Scale-Up 6/2/2026

    Gain insight into a first-time-right process that improved yield and scalability, advancing a vascular calcification inhibitor from lab scale to tox and GMP manufacturing for clinical development.

  10. A Green Synthesis Process For A Growth Promoter Drug For Animals 6/2/2026

    Green chemistry redesigned a growth promoter synthesis, cutting waste and costs while boosting yield, efficiency, and sustainability for scalable animal health manufacturing.